Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNT1 | Q5JUK3 | 20/20 | 0.84 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.79 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.79 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.79 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.79 |
| ▸ | KCNMB1 | Q16558 | 1/20 | 0.79 |
| ▸ | KCNT2 | Q6UVM3 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22637678 | 1.00 | KCNT1 (0.84) | KCNT1KCNQ1KCNH2CACNA1CSCN5A | |
| SCHEMBL22637674 | 1.00 | KCNT1 (0.84) | KCNT1KCNQ1KCNH2CACNA1CSCN5A | |
| SCHEMBL22637941 | 0.92 | KCNT1 (0.81) | KCNT1KCNQ1KCNH2CACNA1CSCN5A | |
| SCHEMBL22637945 | 0.92 | KCNT1 (0.81) | KCNT1KCNQ1KCNH2CACNA1CSCN5A | |
| SCHEMBL29463522 | 0.92 | KCNT1 (0.81) | KCNT1KCNQ1KCNH2CACNA1CSCN5A | |
| SCHEMBL24660776 | 0.91 | KCNT1 (1.00) | KCNT1KCNQ1KCNH2CACNA1CSCN5A | |
| SCHEMBL29463504 | 0.91 | KCNT1 (1.00) | KCNT1KCNQ1KCNH2CACNA1CSCN5A | |
| SCHEMBL24660465 | 0.91 | KCNT1 (1.00) | KCNT1KCNQ1KCNH2CACNA1CSCN5A | |
| SCHEMBL22637201 | 0.91 | KCNT1 (1.00) | KCNT1KCNQ1KCNH2CACNA1CSCN5A | |
| SCHEMBL22637718 | 0.91 | KCNT1 (0.85) | KCNT1KCNQ1KCNH2CACNA1CSCN5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114269340-A | KCNT1 inhibitors and methods of use | 普拉克西斯精密药物股份有限公司 | 2022-04-01 | — | — | CN | disclosed |
| EP-3962481-A1 | KCNT1 INHIBITORS AND METHODS OF USE | Praxis Precision Medicines, Inc. (US) | 2022-03-09 | — | — | EP | disclosed |